Cas:331763-70-3 (3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(4-fluorophenyl)butanoic acid manufacturer & supplier

We serve Chemical Name:(3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(4-fluorophenyl)butanoic acid CAS:331763-70-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(4-fluorophenyl)butanoic acid

Chemical Name:(3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(4-fluorophenyl)butanoic acid
CAS.NO:331763-70-3
Synonyms:MFCD01860915;(3R)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-(4-fluorophenyl)butanoic acid;(R)-3-(Fmoc-amino)-4-(4-fluorophenyl)butyric acid
Molecular Formula:C25H22FNO4
Molecular Weight:419.44500
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:75.63000
Exact Mass:419.15300
LogP:5.14110

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like MFCD01860915 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-3-(Fmoc-amino)-4-(4-fluorophenyl)butyric acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(R)-3-(Fmoc-amino)-4-(4-fluorophenyl)butyric acid Use and application,(3R)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-(4-fluorophenyl)butanoic acid technical grade,usp/ep/jp grade.


Related News: Separately, Europe’s drug regulator said on Friday that batches of J&J COVID-19 vaccine made for the region around the time the contamination issues were revealed at the Baltimore plant would, as a precaution, not be used. (3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(4-fluorophenyl)butanoic acid manufacturer Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. (3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(4-fluorophenyl)butanoic acid supplier Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity. (3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(4-fluorophenyl)butanoic acid vendor Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. (3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(4-fluorophenyl)butanoic acid factory The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.